About: http://data.cimple.eu/news-article/cb6b7903712cbc698371719ffc41555d17e4e910f8af09ee4c180b49

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/cb6b7903712cbc698371719ffc41555d17e4e910f8af09ee4c180b49 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Sweden's Public Health Agency on Thursday announced it was resuming use of AstraZeneca's Covid-19 vaccine after it was put on pause over blood clot fears, but limited it to seniors. Following other European countries, Sweden suspended vaccinations with the AstraZeneca jab in mid-March following reports of severe blood clots potentially linked to the vaccine. Last week the EU drugs regulator EMA said the vaccine was "safe and effective" and not linked to a higher risk of blood clots, but could not "rule out definitively" its role in a rare clotting disorder. While many other nations resumed using the AstraZeneca vaccine following the EMA's announcement, Nordic countries maintained their suspensions pending further checks. "AstraZeneca is a very effective vaccine, and there is a great need for protection against Covid-19 among the elderly. Especially now when we are seeing an increased spread of transmission," state epidemiologist Anders Tegnell told a press conference on Thursday as he announced inoculations should resume. However the jab would be restricted to those over 65, as reports of complications among those younger than that age continued to be investigated. "We are continuing the pause in that group until we have more information about what the risks actually are," Tegnell said. Finland and Iceland made similar announcements earlier in the week, while Denmark said Thursday it was extending its total suspension for another three weeks. A decision from Norway is expected on Friday. According to data from the World Health Organization, Sweden has seen an incidence rate in the last 14 days of 604 cases per 100,000 inhabitants, an increase of 16 percent. Sweden, a country of 10.3 million inhabitants, has so far recorded 773,690 cases of Covid-19 and 13,373 associated deaths. Vaccinations began in late December and as of Wednesday 9.8 percent of the population have received a first dose, while 4.2 percent have been fully vaccinated. jll/po/dl
schema:headline	Sweden resumes use of AstraZeneca jab for seniors
schema:mentions	Notifiable disease Epidemiology Nordic countries Thrombosis European Medicines Agency Iceland Jab Finland Denmark Sweden Norway World Health Organization AstraZeneca European Union Vaccine Coronavirus disease 2019 Coagulopathy Venous thrombosis JLL (company)
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-03-25 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	76 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness
http://data.cimple...entionsConspiracy	antivax conspiracy theory

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software